
    
      This is a Phase I study to evaluate the safety, tolerability, PK of SR419 in healthy
      volunteers. The study will include 3 parts.

      Part A is a double-blind, randomized, placebo-controlled, single-dose escalation study of
      SR419 in healthy young subjects.

      Part B is a double-blind, randomized, placebo-controlled, repeated-dose escalation study of
      SR419 in healthy young subjects.

      Part C is a double-blind, randomized, placebo-controlled, repeated dose study of SR419 in
      healthy elderly subjects.
    
  